Statins and the risk of liver injury: a population‐based case‐control study
- 14 May 2014
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 23 (7) , 719-725
Abstract
Objective: This case‐control study investigated the association between statin use and liver injury using Taiwan's National Health Insurance Research Database.Methods: Our study subjects included 4165 cases (patients who had been admitted with a primary diagnosis of liver injury between 2002 and 2009) and 16 660 age‐matched, sex‐matched and index date‐matched controls. Multivariable conditional regression models were used to estimate the association between statin use and liver injury.Results: Users of statins were not associated with risk of liver injury (adjusted odds ratio [aOR] 1.04; 95% confidence interval [0.90–1.19]) when compared with nonusers. Nevertheless, a higher dose of statin (≥1 defined daily dose; aOR 1.55 [1.14–2.11]) and use of rosuvastatin before event of liver injury (aOR 1.38 [1.03–1.85]) were significantly associated with liver injury.Conclusions: This population‐based study extends previous evidence by exploring the potential association between statins use and risk of liver injury. Overall, we found that statin was not associated with risk of liver injury. Nevertheless, special concern should be paid to those who used statin ≥1 defined daily dose and rosuvastatin. Copyright © 2014 John Wiley & Sons, Ltd.Keywords
Funding Information
- National Science Council, Taiwan (NSC101-3114-Y-002-003)
This publication has 41 references indexed in Scilit:
- 3-hydroxyl-3-methylglutaryl coenzyme A reductase inhibitor use in chronic liver disease: A therapeutic controversyJournal of Clinical Lipidology, 2011
- Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trialsThe Lancet, 2010
- Drug-Induced Liver Injury Associated with StatinsSeminars in Liver Disease, 2009
- Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: A histopathological follow-up studyJournal of Hepatology, 2007
- Risks Associated With Statin TherapyCirculation, 2006
- Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statinsThe Lancet, 2005
- Association of Statin Therapy with Outcomes of Acute Coronary Syndromes: The GRACE StudyAnnals of Internal Medicine, 2004
- Defining patient risks from expanded preventive therapiesThe American Journal of Cardiology, 2000
- Biochemical Changes and Morphological Alterations of the Liver in Guinea‐Pigs after Administration of Simvastatin (HMG CoA Reductase‐Inhibitor)Basic & Clinical Pharmacology & Toxicology, 1990
- Preclinical evaluation of lovastatinThe American Journal of Cardiology, 1988